+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Search in Oncology Drugs returned 5,117 results.

Recurrent Malignant Glioma - Pipeline Insight, 2025 - Product Thumbnail Image

Recurrent Malignant Glioma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Recurrent Or Metastatic Head And Neck Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Recurrent Or Metastatic Head And Neck Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
BRAF-Mutant Metastatic Melanoma - Pipeline Insight, 2025 - Product Thumbnail Image

BRAF-Mutant Metastatic Melanoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Colorectal Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Colorectal Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 550 Pages
  • Global
From
Cutaneous T-cell Lymphoma - Pipeline Insight, 2025 - Product Thumbnail Image

Cutaneous T-cell Lymphoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
HR Positive/ HER2 Negative Breast Cancer- Pipeline Insight, 2025 - Product Thumbnail Image

HR Positive/ HER2 Negative Breast Cancer- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
Endometrial Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Endometrial Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
Fallopian Tube Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Fallopian Tube Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
From
Glioblastoma Multiforme (GBM) - Pipeline Insight, 2025 - Product Thumbnail Image

Glioblastoma Multiforme (GBM) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Glioma - Pipeline Insight, 2025 - Product Thumbnail Image

Glioma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 450 Pages
  • Global
From
HER2-Positive Early Breast Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

HER2-Positive Early Breast Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Indolent Lymphoma - Pipeline Insight, 2025 - Product Thumbnail Image

Indolent Lymphoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Non-Hodgkin Lymphoma - Pipeline Insight, 2025 - Product Thumbnail Image

Non-Hodgkin Lymphoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 450 Pages
  • Global
From
Pancreatic Adenocarcinoma - Pipeline Insight, 2025 - Product Thumbnail Image

Pancreatic Adenocarcinoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Pancreatic Ductal Carcinoma - Pipeline Insight, 2025 - Product Thumbnail Image

Pancreatic Ductal Carcinoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Pancreatic Neuroendocrine Tumors - Pipeline Insight, 2025 - Product Thumbnail Image

Pancreatic Neuroendocrine Tumors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Pediatric Neuroblastoma - Pipeline Insight, 2025 - Product Thumbnail Image

Pediatric Neuroblastoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Peritoneal Carcinomatosis (PC) - Pipeline Insight, 2025 - Product Thumbnail Image

Peritoneal Carcinomatosis (PC) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Primary Myelofibrosis- Pipeline Insight, 2025 - Product Thumbnail Image

Primary Myelofibrosis- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 150 Pages
  • Global
From
Loading Indicator